These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 31164820)
1. Effects of PARP-1 Deficiency and Histamine H Durante M; Sgambellone S; Lanzi C; Nardini P; Pini A; Moroni F; Masini E; Lucarini L Front Pharmacol; 2019; 10():525. PubMed ID: 31164820 [TBL] [Abstract][Full Text] [Related]
2. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis. Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884 [TBL] [Abstract][Full Text] [Related]
3. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment. Rosa AC; Pini A; Lucarini L; Lanzi C; Veglia E; Thurmond RL; Stark H; Masini E J Pharmacol Exp Ther; 2014 Nov; 351(2):308-16. PubMed ID: 25185215 [TBL] [Abstract][Full Text] [Related]
4. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway. Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718 [TBL] [Abstract][Full Text] [Related]
5. Role of histamine H Sgambellone S; Febo M; Durante M; Marri S; Villano S; Bereshchenko O; Migliorati G; Masini E; Riccardi C; Bruscoli S; Lucarini L Inflamm Res; 2023 Nov; 72(10-11):2037-2052. PubMed ID: 37815550 [TBL] [Abstract][Full Text] [Related]
6. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235 [TBL] [Abstract][Full Text] [Related]
7. A Selective Histamine H Dettori I; Gaviano L; Melani A; Lucarini L; Durante M; Masini E; Pedata F Front Pharmacol; 2018; 9():1231. PubMed ID: 30420807 [TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) polymerase-1 (PARP-1) controls lung cell proliferation and repair after hyperoxia-induced lung damage. Pagano A; Métrailler-Ruchonnet I; Aurrand-Lions M; Lucattelli M; Donati Y; Argiroffo CB Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L619-29. PubMed ID: 17575013 [TBL] [Abstract][Full Text] [Related]
9. Adenosine A Sgambellone S; Marri S; Catarinicchia S; Pini A; Tosh DK; Jacobson KA; Masini E; Salvemini D; Lucarini L Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362112 [TBL] [Abstract][Full Text] [Related]
10. Aryl-1,3,5-triazine ligands of histamine H Mogilski S; Kubacka M; Łażewska D; Więcek M; Głuch-Lutwin M; Tyszka-Czochara M; Bukowska-Strakova K; Filipek B; Kieć-Kononowicz K Inflamm Res; 2017 Jan; 66(1):79-95. PubMed ID: 27766379 [TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. Henning RJ; Bourgeois M; Harbison RD Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072 [TBL] [Abstract][Full Text] [Related]
12. Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo. Ehling S; Roßbach K; Dunston SM; Stark H; Bäumer W J Dermatol Sci; 2016 Aug; 83(2):106-15. PubMed ID: 27155791 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of functionally different histamine H Adami M; Micheloni C; Grandi D; Stark H Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1387-1397. PubMed ID: 30145688 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition. Gao L; Jiang D; Geng J; Dong R; Dai H Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412 [TBL] [Abstract][Full Text] [Related]
15. Low-level laser therapy attenuates lung inflammation and airway remodeling in a murine model of idiopathic pulmonary fibrosis: Relevance to cytokines secretion from lung structural cells. de Brito AA; da Silveira EC; Rigonato-Oliveira NC; Soares SS; Brandao-Rangel MAR; Soares CR; Santos TG; Alves CE; Herculano KZ; Vieira RP; Lino-Dos-Santos-Franco A; Albertini R; Aimbire F; de Oliveira AP J Photochem Photobiol B; 2020 Jan; 203():111731. PubMed ID: 31935633 [TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5. Oumouna M; Datta R; Oumouna-Benachour K; Suzuki Y; Hans C; Matthews K; Fallon K; Boulares H J Immunol; 2006 Nov; 177(9):6489-96. PubMed ID: 17056581 [TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effect of co-administered NMDA and histamine H4 receptor antagonists in a rat model of acute pain. Wolińska R; Leśniak A; Żochowska M; Sacharczuk M; Kieć-Kononowicz K; Bujalska-Zadrożny M Pharmacol Rep; 2017 Apr; 69(2):222-228. PubMed ID: 28092808 [TBL] [Abstract][Full Text] [Related]
18. Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis. Kim KW; Kim BM; Lee KA; Lee SH; Firestein GS; Kim HR Sci Rep; 2017 Apr; 7(1):1197. PubMed ID: 28446753 [TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy. Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of histamine H4 receptor on human mast cells. Jemima EA; Prema A; Thangam EB Mol Immunol; 2014 Nov; 62(1):19-28. PubMed ID: 24934979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]